NDC 69448-019 – Imuldosa
Ustekinumab-srlf 130 mg/26mL · Injection · Intravenous
Product NDC69448-019
Product details
- Brand name
- Imuldosa
- Generic name
- Ustekinumab-srlf
- Labeler
- Accord BioPharma Inc.
- Dosage form
- Injection
- Route
- Intravenous
- Marketing category
- BLA · BLA761364
- Marketed since
- October 18, 2024
- Listing expires
- December 31, 2027
- Pharmacologic class
- Interleukin-12 Antagonist; Interleukin-23 Antagonist
Active ingredients
- Ustekinumab-srlf 130 mg/26mL
Package NDC codes (1)
| Package NDC | Description | Since |
|---|---|---|
| 69448-019-26 | 1 VIAL, SINGLE-USE in 1 CARTON (69448-019-26) / 26 mL in 1 VIAL, SINGLE-USE | Oct 18, 2024 |
Recalls mentioning this NDC
- D-0653-2026 Jul 8, 2026 · Class II
Lack of assurance of Sterility: